IMCOR, Alliance, Molecular Biosystems, and GE Healthcare enter into cross-licensing agreement for ultrasound contrast patents.

BIOTECH Patent News, September, 2005

IMCOR Pharmaceutical Co. (San Diego, CA), Alliance Pharmaceutical Corppration (San Diego, CA) and its wholly owned subsidiary, Molecular Biosystems, Inc., have concluded an agreement with GE Healthcare Ltd., resolving disputed patent claims in the case captioned IMCOR Pharmaceutical Co, Alliance Pharmaceutical Corp. and Molecular Biosystems, Inc. v. Amersham Health, Inc., Amersham Health AS and Amersham plc., Civil Action No. 03-2853 (SRC), filed in the United States District Court, District of New Jersey.

Under the terms of the settlement, all parties granted each other a non-exclusive, royalty-free cross-license with the right to sub-license their respective ultrasound contrast agents. The parties will have the right to further develop and commercialize...

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
Click Here
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement
Click Here